Xanodyne Pharmaceuticals, Inc. · Newport, KY United States
| 1 Riverfront Place | Phone: 859-371-6383 |
| Newport, KY | Fax: 859-371-6391 |
| 41071 | |
| United States | 
Map This Company |
Xanodyne Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Cosmetics & Toiletries WholesalersCompany Description
Xanodyne Pharmaceuticals is out to create a medicinal Xanadu. The company primarily develops and manufactures drugs for pain management. Its commercial offerings include pain treatments Hycet, Roxicodone, Oramorph SR, and Zipsor. In addition, the company markets the Duet and Stuart lines of prenatal vitamins. Xanodyne has several other drugs in development, including one for mild to moderate pain in late-stage clinical trials. The firm funds its development efforts through sales of its commercial products, which are marketed through an internal specialty sales force that targets pain specialists and women's healthcare physicians in the US.
Xanodyne Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PrivateHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 125 |
Executives
24 executives listed for Xanodyne Pharmaceuticals, Inc.'s Newport, KY location.
| Chairman | Rolf Classon | |
|---|---|---|
| President, CEO, and Director | Natasha Giordano | |
| Chief Financial and Information Officer | Rita O'Connor |